Abstract
Quality of surgery has recently become an important topic in the management of colon cancer. Both en bloc resection and resection of an adequate area of colon and mesocolon are mandatory for high-quality surgery. The quality of surgery is assessed by pathologic evaluation, including morphologic assessment of the plane of dissection, length of colon resected, length of the high tie vascular ligation of the mesenteric artery to the colon, and the number of lymph nodes studied. Morphologic assessment is a qualitative measure of the plane of dissection, and smooth dissection could contribute to good prognosis. The other measures are quantitative and reflect the area of colon and mesocolon resected. Adequate resection area could not only lead to a good prognosis but also enable accurate staging in colon cancer. In this section, we discuss the relationship between quality of surgery and pathologic assessment, highlighting the difference between D3 dissection in Asian countries and complete mesocolic excision (CME) in Western countries. Precise estimation of tumor depth is also considered critical for predicting prognosis in colon cancer. In particular, it is crucial to discriminate a T4 lesion from a T3 lesion, because the former is a potential risk factor for recurrence of disease. However, accurate diagnosis is difficult. We introduce our method of pathologic examination for differentiating these lesions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
den Dulk M, van de Velde CJ. Time to focus on the quality of colon-cancer surgery. Lancet Oncol. 2008;9:815–7.
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation--technical notes and outcome. Color Dis. 2009;11:354–64.
West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010;28:272–8.
Bertelsen CA, Bols B, Ingeholm P, Jansen JE, Neuenschwander AU, Vilandt J. Can the quality of colonic surgery be improved by standardization of surgical technique with complete mesocolic excision? Color Dis. 2011;13:1123–9.
Quirke P, West N. Quality of surgery: has the time come for colon cancer? Lancet Oncol. 2015;16:121–2.
West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9:857–65.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.
Kobayashi H, West NP, Takahashi K, Perrakis A, Weber K, Hohenberger W, et al. Quality of surgery for stage III colon cancer: comparison between England, Germany, and Japan. Ann Surg Oncol. 2014;21(Suppl 3):S398–404.
Culligan K, Sehgal R, Mulligan D, Dunne C, Walsh S, Quondamatteo F, et al. A detailed appraisal of mesocolic lymphangiology--an immunohistochemical and stereological analysis. J Anat. 2014;225:463–72.
Gao Z, Ye Y, Zhang W, Shen D, Zhong Y, Jiang K, et al. An anatomical, histopathological, and molecular biological function study of the fascias posterior to the interperitoneal colon and its associated mesocolon: their relevance to colonic surgery. J Anat. 2013;223:123–32.
Munkedal DL, Laurberg S, Hagemann-Madsen R, Stribolt KJ, Krag SR, Quirke P, et al. Significant individual variation between pathologists in the evaluation of colon cancer specimens after complete mesocolic excision. Dis Colon Rectum. 2016;59:953–61.
Japanese Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma, 2nd ed. (English). Tokyo: Kanehara; 2009.
Kawada H, Kurita N, Nakamura F, Kawamura J, Hasegawa S, Kotake K, et al. Incorporation of apical lymph node status into the seventh edition of the TNM classification improves prediction of prognosis in stage III colonic cancer. Br J Surg. 2014;101:1143–52.
Kotake K, Mizuguchi T, Moritani K, Wada O, Ozawa H, Oki I, et al. Impact of D3 lymph node dissection on survival for patients with T3 and T4 colon cancer. Int J Color Dis. 2014;29:847–52.
Lu JY, Xu L, Xue HD, Zhou WX, Xu T, Qiu HZ, et al. The radical extent of lymphadenectomy - D2 dissection versus complete mesocolic excision of laparoscopic right colectomy for right-sided colon cancer (RELARC) trial: study protocol for a randomized controlled trial. Trials. 2016;17:582.
Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gómez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases. Dis Colon Rectum. 1994;37:373–6.
Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes’ B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83:666–72.
Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408–19.
Schmoll HJ, Van Cutsem E, Stein A, Valentini V, Glimelius B, Haustermans K, et al. ESMO consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making. Ann Oncol. 2012;23:2479–516.
Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.
Hoshino N, Hasegawa S, Hida K, Kawada K, Sugihara K, Sakai Y. Impact of age on the prognostic value of number of lymph nodes retrieved in patients with stage II colorectal cancer. Int J Color Dis. 2016;31:1307–13.
Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010;28:264–71.
Lan YT, Yang SH, Chang SC, Liang WY, Li AF, Wang HS, et al. Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Color Dis. 2012;27:657–63.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hoshino, N., Hida, K., Sakurai, T., Sakai, Y. (2018). Pathologic Assessment and Specimen Quality of Surgery After CME. In: Kim, N., Sugihara, K., Liang, JT. (eds) Surgical Treatment of Colorectal Cancer. Springer, Singapore. https://doi.org/10.1007/978-981-10-5143-2_25
Download citation
DOI: https://doi.org/10.1007/978-981-10-5143-2_25
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-5142-5
Online ISBN: 978-981-10-5143-2
eBook Packages: MedicineMedicine (R0)